AngioDynamics saw the highest growth of 199% in patent filings and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 199% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of AngioDynamics‘s patent filings and grants. Buy the databook here.
AngioDynamics has been focused on protecting inventions in United States(US) with 21 publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 52% filings and 62% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and South Korea(KR) patent Office are among the top ten patent offices where AngioDynamics is filings its patents. Among the top granted patent authorities, AngioDynamics has 62% of its grants in United States(US), 25% in European Patent Office(EPO) and 12% in Poland(PL).
General surgery devices related patents lead AngioDynamics portfolio followed by cardiovascular devices, and laparoscopic trocars
See Also:
AngioDynamics has highest number of patents in general surgery devices followed by cardiovascular devices, laparoscopic trocars, dermatitis (eczema), and atopic dermatitis (atopic eczema). For general surgery devices, nearly 50% of patents were filed and 50% of patents were granted in Q4 2023.
For comprehensive analysis of AngioDynamics's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.